IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q2 2017 Holdings

Filed 2017-08-14 | 16 holdings | $13.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics Inc(ADMA)COM000899104$13.4M3,608,17195.9%
Loxo Oncology IncCOM548862101$335.9K4,188,9202.4%
Aimmune Therapeutics Inc.(AIMT)COM00900T107$61.5K2,990,0000.4%
Viewray Inc.(VRAYQ)COM92672L107$48.4K7,480,8870.3%
Esperion Therapeutics Inc.(ESPR)COM29664W105$38.7K837,1250.3%
Versartis IncCOM92529L102$35.3K2,024,4650.3%
Paratek Pharmaceuticals IncCOM699374302$11.6K482,6800.1%
Syros Pharmaceuticals, Inc.COM87184Q107$8.2K508,5650.1%
Cidara Therapeutics Inc.COM171757107$7.7K1,021,1480.1%
Transenterix Inc.COM NEW89366M201$7.3K10,335,8190.1%
Agile Therapeutics Inc(AGRXUSD)COM00847L100$6.8K1,804,9330.0%
T2 Biosystems IncCOM89853L104$4.9K1,523,4990.0%
Chimerix Inc.(CMRXEUR)COM16934W106$2.6K472,9430.0%
Pernix Therapeutics Hldgs inCOM NEW71426V306$844210,0000.0%
Pernix Therapeutics Hldgs IncDBCV 4.250% 4/071426VAK4$775$2,500,0000.0%
Zeltiq Aesthetics IncCOM98933Q108$011,9850.0%